Pediatric posterior reversible encephalopathy syndrome: Age related clinico-radiological profile and neurologic outcomes

被引:1
|
作者
Ekinci, Faruk [1 ]
Yildizdas, Dincer [1 ]
Horoz, Ozden Ozgur [1 ]
Gul Mert, Gulen [2 ]
Kaya, Omer [3 ]
Bayram, Ibrahim [4 ]
Atmis, Bahriye [5 ]
Leblebisatan, Goksel [6 ]
Sezgin, Gulay [4 ]
Yavas, Damla Pinar [1 ]
机构
[1] Cukurova Univ, Dept Pediat Intens Care, Fac Med, Adana, Turkiye
[2] Cukurova Univ, Dept Pediat Neurol, Fac Med, Adana, Turkiye
[3] Cukurova Univ, Dept Radiol, Fac Med, Adana, Turkiye
[4] Cukurova Univ, Dept Pediat Oncol, Fac Med, Adana, Turkiye
[5] Cukurova Univ, Dept Pediat Nephrol, Fac Med, Adana, Turkiye
[6] Cukurova Univ, Dept Pediat Hematol, Fac Med, Adana, Turkiye
关键词
magnetic resonance imaging; outcome; pediatric; posterior reversible encephalopathy syndrome; risk factor; PRES; CHILDREN; MANIFESTATION; ECLAMPSIA;
D O I
10.1111/ped.15562
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: The aim of this study was to analyze the characteristics of pediatric posterior reversible encephalopathy syndrome (PRES) to determine clinical and radiologic differences between younger and older age groups, and to identify risk factors for development of any neurologic sequelae. Methods: The study cohort consisted of confirmed pediatric PRES patients in a tertiary care university hospital from January, 2015, to December, 2020. Demographic and clinical properties, radiological manifestations, and neurologic outcomes were noted. Children aged <= 6 years were compared with those older than 6 years and factors affecting neurologic outcomes were evaluated. Results: The most common underlying diseases were oncological (37%) and kidney diseases (29%). Epileptic seizures were the most frequent symptoms at initial clinical presentation. The regions in the brain that were most commonly involved were the occipital region (n = 65, 96%), the parietal region (n = 52, 77%), and the frontal lobe (n = 35, 54%). Magnetic resonance imaging (MRI) findings were consistent with atypical patterns in most of the study cohort (71%). Patients with unfavorable clinical outcomes (n = 13, 19.1%) had longer initial seizure times and longer encephalopathy times, lower leucocyte and absolute neutrophil counts, and lower neutrophil to lymphocyte ratios. No relationship was found between MRI findings, involvement patterns, and neurologic outcomes. Conclusions: No clinically specific differences between two different age groups were found. Atypical imaging manifestations of pediatric PRES in our study had an incidence that was as high as those found in earlier adult studies. Multivariate logistic regression analysis showed that the initial neutrophil to lymphocyte ratio, absolute neutrophil counts, and white cell counts could not predict poor neurologic outcomes.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] A survey on hematology-oncology pediatric AIEOP centres: The challenge of posterior reversible encephalopathy syndrome
    Zama, Daniele
    Gasperini, Pietro
    Berger, Massimo
    Petris, Mariagrazia
    De Pasquale, Maria D.
    Cesaro, Simone
    Guerzoni, Maria E.
    Mastrodicasa, Elena
    Savina, Francesca
    Ziino, Ottavio
    Kiren, Valentina
    Muggeo, Paola
    Mura, Rosa M.
    Melchionda, Fraia
    Zanazzo, Giulio A.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 100 (01) : 75 - 82
  • [42] Clinical features and outcomes of children admitted to the pediatric intensive care unit due to posterior reversible encephalopathy syndrome
    Gun, Emrah
    Sen Akova, Birsel
    Botan, Edin
    Celik, Dilara Besli
    Balaban, Burak
    Ozen, Hasan
    Gencay, Ali Genco
    Bektas, Omer
    Fitoz, Suat
    Kendirli, Tanil
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2022, 222
  • [43] Guillain Barr, syndrome-related posterior reversible encephalopathy syndrome
    Zuccoli, Giulio
    Nardone, Raffaele
    Hoda, Abdel-Hamid
    NEURORADIOLOGY, 2015, 57 (07) : 755 - 756
  • [44] Guillain Barré syndrome-related posterior reversible encephalopathy syndrome
    Giulio Zuccoli
    Raffaele Nardone
    Abdel-Hamid Hoda
    Neuroradiology, 2015, 57 : 755 - 756
  • [45] Epidemiology, Comorbidities, and Outcomes of Posterior Reversible Encephalopathy Syndrome in Children in the United States
    Thavamani, Aravind
    Umapathi, Krishna Kishore
    Puliyel, Mammen
    Super, Dennis
    Allareddy, Veerajalandhar
    Ghori, Abdulla
    PEDIATRIC NEUROLOGY, 2020, 103 : 21 - 26
  • [46] Pediatric Reversible Cerebral Vasoconstriction Syndrome/Posterior Encephalopathy Syndrome/Poststreptococcal Glomerulonephritis
    Kawashima, Yuki
    Ariji, Shohei
    Aoyagi, Rui
    Noda, Masahiro
    Oba, Kunihiro
    Ogasawara, Masashi
    PEDIATRIC NEUROLOGY, 2024, 155 : 33 - 35
  • [47] Posterior reversible encephalopathy syndrome: 5 chemotherapy related cases
    San Martin Garcia, I.
    Urabayen Alberdi, R.
    Diez Bayona, V.
    de Ilurdoz Uranga, M. Sagaseta
    Esparza Estaun, J.
    Molina Garicano, J.
    Berisa Prado, S.
    ANALES DE PEDIATRIA, 2014, 80 (02): : 117 - 121
  • [48] Clinical Profile and Outcome of Posterior Reversible Encephalopathy Syndrome in Hemodialysis Patients
    Chandragiri, S.
    Surendra, M.
    Raju, S.
    Sridhar, N.
    Ramesh, B.
    Raju, N.
    INDIAN JOURNAL OF NEPHROLOGY, 2018, 28 (04) : 283 - 286
  • [49] Posterior Reversible Encephalopathy Syndrome: Incidence and Associated Factors in a Pediatric Critical Care Population
    Raj, Shashi
    Overby, Philip
    Erdfarb, Amichai
    Ushay, H. Michael
    PEDIATRIC NEUROLOGY, 2013, 49 (05) : 335 - 339
  • [50] Posterior Reversible Encephalopathy Syndrome in a Pediatric Patient with End-Stage Renal Disease
    Popa, Ionela-Loredana
    Balgradean, Mihaela
    Costin, Mariana
    Bobirca, Anca
    Bologa, Cristina
    Armaselu, Teodora
    Bobirca, Florin
    Croitoru, Anca
    CHILDREN-BASEL, 2023, 10 (04):